Scribe Therapeutics Reports Preclinical Data at ASGCT 2026 Demonstrating Enhanced Potency and Specificity of Engineered CRISPR Technologies for Epigenetic Silencing and Gene Editing Scribe Therapeutics, Inc. a biotechnology company engineering purpose-built CRISPR technologies to reshape the treatment of disease by…
Next Health in Peoria Hosting Grand Opening, Bringing Advanced Longevity & Preventive Health Services to Arizona Next Health, the world’s most advanced and comprehensive brand of health optimization and longevity centers, invites the community and media to its newest location in…
Butterfly Network Appoints Caroll H. Neubauer to Board of Directors Butterfly Network, Inc. a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Caroll H. Neubauer to its Board of Directors, effective…
Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB Two River, LLC and Vida Ventures both part of the Bellco Health ecosystem, acknowledged the announced acquisition of Candid…
Atropos Health Creates World’s Largest Body of Medical Evidence, Alexandria, for Clinical Decision Support and LLM Training to Improve Patient, Life Science, and Medical Outcomes Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, announced…
Volastra Therapeutics Announces Biomarker and Combination Data around AACR 2026 Defining an Rb Pathway-Driven Pan-Cancer Development Strategy for KIF18A Inhibitors Volastra Therapeutics, a clinical-stage oncology company pioneering therapies targeting chromosomal instability (CIN), announced multiple scientific disclosures coinciding with the American…
Horizon Quantum and AQT to Advance Real-World Quantum Applications with Strategic Hardware–Software Collaboration Horizon Quantum Computing Pte. Ltd., the wholly-owned subsidiary of Horizon Quantum Holdings Ltd.a pioneer of software infrastructure for quantum applications, and AQT (Alpine Quantum Technologies), a leading…
Switch Automation and Berkeley Lab Advance Next Generation of Smart Buildings—From Analytics to Autonomous Operations Switch Automation, a global provider of smart building software, today announced the release of new product capabilities in Switch OpX (Operational Excellence), developed in collaboration…
Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS Travere Therapeutics, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients…
Cartherics and Catalent Expand Commercial License Agreement Cartherics Pty Ltd, a biotechnology company developing off‑the‑shelf immune cell therapies for high‑impact women’s diseases, including ovarian cancer and endometriosis, and Catalent, Inc., the leader in enabling the development and supply of better…
Infleqtion and NASA Deliver Next-Generation Quantum Capabilities to International Space Station Infleqtion a global leader in quantum computing and quantum sensing powered by neutral-atom technology, is providing upgraded quantum hardware to the International Space Station (ISS) via NASA’s Northrop Grumman-24 (NG-24)…
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Pulse Biosciences, Inc. developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first…